These are real, verified funds with a digital health line in their thesis – ticket ranges and fund sizes shown only where the fund has actually disclosed them. Ranked by data completeness and stage relevance.
Bpifrance
France's public investment bank, the single largest actor in French venture capital, investing directly through Digital Venture (seed/Series A) and Large Venture (a €2.5B vehicle for rounds above €20M). Portfolio includes Doctolib, one of Europe's largest digital-health platforms.
Omnes Capital
A French private-assets manager with over €6.7B under management. Has backed life-sciences and health names including Iktos, Therapixel, SeqOne Genomics and Qubit Pharmaceuticals, alongside its deeptech and defence portfolio.
Apollo Health Ventures
A Berlin investor and company builder targeting ageing and age-related disease, working across Europe and the US in neurodegeneration, precision oncology and RNA-guided medicines. Its Venture Lab co-founds new companies with scientific founders alongside conventional investing.
Zinc
Backs entrepreneurs from the earliest stages of company creation, turning scientific breakthroughs across health and environmental challenges into scalable UK businesses.
All four funds above disclose a fund size or specialised thesis directly; ticket ranges are not yet fully verified for every fund in this vertical.